UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5101
Camtek
CAMT
$7.56B
| $370K | ﹤0.01% |
34,191
+12,575
| +58% | +$131K |
|
5102
Greif Class B
GEF.B
$4.22B
| $370K | ﹤0.01% |
7,142
+2,077
| +41% | +$103K |
|
5103
ALPS Strategic Income Fund
RIGS
$60.5M
| $370K | ﹤0.01% |
14,889
-5,635
| -27% | -$140K |
|
5104
Zumiez
ZUMZ
$322M
| $370K | ﹤0.01% |
10,702
+9,339
| +685% | +$295K |
|
5105
PUT
Corteva
CTVA
$51B
| $369K | ﹤0.01% |
12,473
+2,198
| +21% | +$58.2K |
|
5106
Ardelyx
ARDX
$999M
| $368K | ﹤0.01% |
49,068
+12,202
| +33% | +$74.1K |
|
5107
EQT Corp
EQT
$33.7B
| $368K | ﹤0.01% |
33,811
-101,705
| -75% | -$995K |
|
5108
CALL
Expedia Group
EXPE
$38.4B
| $368K | ﹤0.01% |
3,400
| – | – |
|
5109
Invesco Total Return Bond ETF
GTO
$2.47B
| $368K | ﹤0.01% |
6,784
+769
| +13% | +$41.8K |
|
5110
Red River Bancshares
RRBI
$664M
| $368K | ﹤0.01% |
6,562
+4,914
| +298% | +$234K |
|
5111
XBiotech
XBIT
$69.5M
| $368K | ﹤0.01% |
19,693
+14,594
| +286% | +$188K |
|
|
BFIN
5112
DELISTED
BankFinancial
BFIN
| $367K | ﹤0.01% |
28,062
+15,398
| +122% | +$200K |
|
5113
China Automotive Systems
CAAS
$139M
| $367K | ﹤0.01% |
116,586
-917
| -0.8% | -$2.41K |
|
5114
Cardlytics
CDLX
$21.6M
| $367K | ﹤0.01% |
584
-308
| -35% | -$151K |
|
|
TURN
5115
DELISTED
180 Degree Capital
TURN
| $367K | ﹤0.01% |
56,867
-1,565
| -3% | -$10K |
|
|
LCI
5116
DELISTED
Lannett Company, Inc.
LCI
| $367K | ﹤0.01% |
10,388
+7,043
| +211% | +$286K |
|
|
AVNS
5117
DELISTED
Avanos Medical
AVNS
| $366K | ﹤0.01% |
10,860
-1,342
| -11% | -$48.6K |
|
|
AZUL
5118
DELISTED
Azul
AZUL
| $366K | ﹤0.01% |
8,554
+3,241
| +61% | +$125K |
|
5119
Banco Santander Chile
BSAC
$16.6B
| $366K | ﹤0.01% |
15,874
+7,608
| +92% | +$189K |
|
5120
Western New England Bancorp
WNEB
$278M
| $366K | ﹤0.01% |
38,022
+12,302
| +48% | +$119K |
|
|
EMWP
5121
DELISTED
Eros Media World PLC
EMWP
| $366K | ﹤0.01% |
5,392
+2,170
| +67% | +$101K |
|
|
ACV
5122
Virtus Diversified Income & Convertible Fund
ACV
$286M
| $365K | ﹤0.01% |
14,809
+26
| +0.2% | +$622 |
|
5123
Culp Inc
CULP
$43.4M
| $365K | ﹤0.01% |
26,746
+6,587
| +33% | +$101K |
|
|
MCBC
5124
DELISTED
Macatawa Bank Corp
MCBC
| $365K | ﹤0.01% |
32,786
+10,394
| +46% | +$111K |
|
|
FCBP
5125
DELISTED
First Choice Bancorp Common Stock
FCBP
| $365K | ﹤0.01% |
13,555
-135,161
| -91% | -$3.11M |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.